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University of Cape Town, Cape Town, South Africa.N-(p-amylcinnamoyl)anthranilic acid (ACA), a phospholipase A2 (PLA2) inhibitor, is structurally-related to
non-steroidal anti-inflammatory drugs (NSAIDs) of the fenamate group and may also modulate various
ion channels. We used the whole-cell, patch-clamp technique at room temperature to investigate the
effects of ACA on the Ca2+-activated chloride current (ICl(Ca)) and other chloride currents in isolated pig
cardiac ventricular myocytes. ACA reversibly inhibited ICl(Ca) in a concentration-dependent manner
(IC50 = 4.2 lM, nHill = 1.1), without affecting the L-type Ca2+ current. Unlike ACA, the non-selective PLA2
inhibitor bromophenacyl bromide (BPB; 50 lM) had no effect on ICl(Ca). In addition, the analgesic NSAID
structurally-related to ACA, diclofenac (50 lM) also had no effect on ICl(Ca), whereas the current in the
same cells could be suppressed by chloride channel blockers flufenamic acid (FFA; 100 lM) or
4,40-diisothiocyanostilbene-2,20-disulfonic acid (DIDS;100 lM). Besides ICl(Ca), ACA (50 lM) also sup-
pressed the cAMP-activated chloride current, but to a lesser extent. It is proposed that the inhibitory
effects of ACA on ICl(Ca) are PLA2-independent and that the drug may serve as a useful tool in understand-
ing the nature and function of cardiac anion channels.
 2010 Elsevier Inc. All rights reserved.2+1. Introduction
Chloride channels that are activated by intracellular Ca2+ are
present in various tissues where they are involved in different
physiological functions [1]. In the heart, Ca2+-activated Cl currents
(ICl(Ca)) have been identified in atria [2], ventricles [3–5] and Pur-
kinje fibres [6] of different animal species. Functionally, the cardiac
ICl(Ca) participates in the early phase of repolarization during an ac-
tion potential [3,7]. Under disease conditions, the transient inward
component of ICl(Ca) has been implicated in arrhythmogenesis [8,9].ll rights reserved.
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, Faculty of Health Sciences,Despite the importance of Ca -activated chloride channels,
progress in understanding their structure, function and regulation
has been limited by the uncertainty about the underlying channel
protein and a lack of specific antibodies (see [10] for review). As a
result, pharmacological agents still provide the major tools to
study these channels. The agents include structurally diverse
chemicals such as 5-nitro-2-(3-phenylpropylamino)-benzoic acid
(NPPB), disulfonic stilbene derivatives like 4,40-diisothiocyanostil-
bene-2,20-disulfonic acid (DIDS) and the non-steroidal anti-inflam-
matory drugs (NSAIDs) of the fenamate group like flufenamic and
niflumic acids. However, most of the drugs available to inhibit
Ca2+-activated Cl channels are only effective at high concentra-
tions and are non-specific. For example, NPPB also blocks L-type
Ca2+ currents [11], whereas niflumic acid not only inhibits but also
partly stimulates ICl(Ca) [12] and may cause release of Ca2+ from
intracellular stores [13,14]. In addition, disulfonic stilbene deriva-
tives are mostly effective at high concentrations and their effects
are not readily reversible. Consequently, additional drugs that
modulate ICl(Ca) could be valuable in developing more specific
inhibitors as well as in providing further insights into the func-
tional role and nature of the channels. Among drugs structurally-
related to fenamates is N-(p-amylcinnamoyl)anthranilic acid
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we show that ACA inhibits ICl(Ca) in a concentration-dependent
manner without affecting L-type Ca2+ currents.2. Materials and methods
2.1. Cell isolation and electrophysiology techniques
The study was approved by the Ethical Commission on Animal
Experiments of the University of Leuven and carried out according
to the institutional guidelines for laboratory animal care. We used
ventricular myocytes dissociated from pig by methods described in
detail before [16–18]. Briefly, pigs were anesthetized with sodium
pentobarbitone (5–15 mg kg1 I.V.), intubated and ventilated, and
then injected with heparin (5–8 mg kg1 I.V.) and a sodium pento-
barbitone overdose (100 mg kg1) before tissue extraction. Cells
were dissociated by enzymatic tissue digestion during Langendorff
perfusion. All experiments were performed at room temperature.
The voltage-clamp protocols consisted of either steps from the
holding potential of 80 mV to various levels or 4-s symmetrical
ramps from 120 to +80 mV and back to 120 mV, applied every
10 s. During the ascending limb of the ramp, the slow rate of
depolarization (0.1 V/s) allowed activation and inactivation of the
voltage-dependent Na+ current. Currents were measured during
the descending limb of the ramp. The pClamp 8.1 software was
used to generate voltage protocols and to record data via a Digidata
1322A acquisition system (Axon instruments, Union City, CA,
USA).
2.2. Solutions and drugs
The standard Tyrode solution used during cell dissociation con-
tained (inmM): 135NaCl, 5.4 KCl, 0.9MgCl2, 1.8 CaCl2, 0.33NaH2PO4,
10 HEPES and 10 glucose; pHwas adjusted to 7.4 with NaOH. During
voltage clamp measurements, cells were superfused with a solution
of similar composition except that K+ was replaced by Cs+. When
studying Ca2+-activated Cl currents, Na+-free solutions (with Na+ re-
placedbyNMDG+)wereused to eliminate thevoltage-dependentNa+
currents. For low Cl solutions, Cl was replaced by glutamate or by
methylsulfate. The standard pipette solution contained (inmM): 130
Cs-glutamate, 25 TEA-Cl, 5.5 MgCl2, 5 Na2ATP, 1 EGTA, 0.1 Na2GTP, 5
HEPES (pH 7.25; adjusted with CsOH) and was modified in a few
experiments by replacing EGTA with BAPTA.
ACA was obtained from Tebu-Bio (Boechout, Belgium). All other
drugs or chemicals were from Sigma–Aldrich (Bornem, Belgium) or
Merck (Darmstadt, Germany). Nifedipine was prepared as stock
solution in ethanol, whereas ACA, bromophenacyl bromide, DIDS,
flufenamic acid and forskolin were prepared in DMSO. All other
chemicals were dissolved in water.
2.3. Data and statistical analyses
Data were analyzed using Clampfit 8.2 (Axon Instruments) and
Origin 7 (Microcal, USA). The following Hill equation was used to
fit the inhibiting effects of ACA as a function of concentration:
Relative current ¼ I½D=Imax ¼ 1=½1þ ð½D=IC50ÞnHill ;
where I[D] is the current at a given drug concentration [D], Imax is the
current in the absence of the drug, IC50 is the drug concentration for
50% inhibition, and nHill is the Hill coefficient. Average data are ex-
pressed as mean ± standard error of the mean, with n indicating the
number of cells studied. Means were compared using the two-tailed
Student’s t-test. P 6 0.05 was taken as threshold for statistical
significance.3. Results
3.1. The Ca2+-activated chloride current (ICl(Ca)) in pig cardiac
ventricular myocytes
Fig. 1A illustrates typical whole-cell current traces obtained
using voltage steps between 80 and +60 mV (see inset) in Na+-
free conditions. The steps induced capacitive transients, which
(at potentials >40 mV) were followed by short-lived biphasic cur-
rents with brief inward and prominent outward components
(Fig. 1A, panel a; see also left panels of Figs. 2A and 3B and C). Both
inward and outward currents could be completely suppressed by
nifedipine (5–100 lM; n = 15; not illustrated), suggesting that
the biphasic currents may be due to superimposed inward L-type
Ca2+ currents (ICa,L) and a Ca2+-activated outward current. We
tested the hypothesis that the outward current was a Cl current
(ICl(Ca)) by removing extracellular chloride (Cl

o ) and by using Cl

channels inhibitors. When Clo was replaced by glutamate, the cur-
rents induced by depolarization became monophasic inward with
no outward component (Fig. 1A, panel b). This effect was reversible
upon re-admission of Clo (Fig. 1A, panel c). In the presence of Cl

o ,
flufenamic acid (100 lM), a known Cl channel inhibitor, sup-
pressed the outward transients, leaving inward currents resem-
bling those in Cl-free solutions (Fig. 1A, panel d; similar results
in seven cells). DIDS (100 lM), another Cl channel inhibitor, also
suppressed the outward transients, but to a lesser extent (n = 4;
not illustrated). Fig. 1B shows that the Cl-dependent current, cal-
culated as the difference between the current in the presence of Clo
and that after Clo removal, had a maximum value (1.46 ± 0.26 pA/
pF; n = 5) at +25 mV. Furthermore, in five other cells dialyzed with
10 mM BAPTA-containing solution and treated with 10 lM ryano-
dine in the external solution to prevent sarcoplasmic Ca2+ release,
only ICa,L was observed (see Fig. 2B, left panel), demonstrating a
dependence of the outward current on intracellular Ca2+. Taken to-
gether, these results indicate that the transient outward current
observed in our experiments is ICl(Ca) and are consistent with those
by others showing the presence of ICl(Ca) in pig ventricular myo-
cytes [19].
In contrast to the effect on the transient currents elicited at
potentials >40 mV, the removal of Clo did not affect the steady-
state current in the same cells (Fig. 1C), indicating that the Clo re-
moval was not altering background conductance.3.2. Effects of N-(p-amylcinnamoyl)anthranilic acid (ACA)
We then tested the effect of ACA on ICl(Ca). Fig. 2 shows currents
obtained using depolarizing steps, in control conditions and in the
presence of ACA. Upon application of ACA (20 lM) outward com-
ponents were suppressed (Fig. 2A, middle panel), an effect that
was reversible upon drug washout (not illustrated). The ACA-sen-
sitive current at various potentials (calculated as the difference be-
tween control current and the current during ACA application) is
shown in Fig. 2A (right panel). Its current–voltage relationship in
five cells (Fig. 2C, open symbols) is similar to that of the Cl-depen-
dent current (see Fig. 1B). To exclude the possibility that the effect
of ACA could be due to an enhancement of ICa,L, with a masking of a
superimposed outward current, we tested the effect of ACA under
conditions where intracellular Ca2+ release was inhibited with
ryanodine and cytosolic Ca2+ was highly buffered with BAPTA. Out-
ward transients were absent in BAPTA-dialyzed and ryanodine-
treated cells (Fig. 2B, left panel), and the control current (ICa,L
uncontaminated by ICl(Ca)) was not affected by ACA (Fig. 2B, middle
panels; 103 ± 7% of control at 0 mV; P = 0.548 compared with con-
trol; paired t-test, n = 5), i.e. the ACA-sensitive current was practi-
cally zero at all tested voltages (Fig. 2B, right panel, and C, filled
Fig. 1. Presence of a Ca2+-activated Cl current in pig ventricular myocytes. (A) Traces of whole-cell currents induced by voltage steps from 80 mV to various levels
(between 80 and +60 mV; see inset) in a pig ventricular myocyte dialyzed with the standard internal solution and superfused with Na+-free, NMDG+-containing solution.
Panel a: typical currents in the presence of extracellular chloride (Clo ): capacitive currents followed by inward and outward transient currents. Panel b: effect of removing Cl

o
(Cl replaced by glutamate). Notice the absence of outward transient currents after the capacitive currents. Panel c: effect of re-admission of Clo . Panel d: effect of adding
extracellular flufenamic acid (FFA; 100 lM) in the presence of Clo . (B and C) Voltage-dependence of peak (B) or steady-state (C) Cl

o -sensitive current. The Cl

o -sensitive
current was calculated as difference between the currents in the presence and after the removal of Clo . The end-of-pulse current was taken as steady-state.
Fig. 2. Suppression of ICl(Ca) by N-(p-amylcinnamoyl)anthranilic acid (ACA). (A) Traces of currents induced by depolarizing steps from 80 mV to various levels (between 80
and +20 mV; see inset) in a cell dialyzed with the standard internal solution and superfused with Na+-free solution. Left panel: the control current. Middle panel: the current
during application of ACA (20 lM). Right panel: the ACA-sensitive current calculated as the difference between the control current and that during ACA application. (B)
Similar protocol as in (A), but in a cell dialyzed with BAPTA (10 mM)-containing solution and treated with ryanodine (10 lM) in the external solution. (C) Current–voltage
relationships of the ACA-sensitive current under control conditions (s) and in BAPTA- and ryanodine-treated cells (d). *Indicates P < 0.05 versus control in the potential range
indicated by horizontal bar (unpaired t-test). (D) Effects of different concentrations of ACA on ICl(Ca) (IC50 = 4.2 lM, nHill = 1.1). Currents are expressed relative to the 100 lM
flufenamic acid-sensitive current.
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trols; unpaired t-test, n = 5). These results indicate that the effectof ACA under standard conditions is due to a suppression of ICl(Ca),
and that the drug has no effect on L-type Ca2+ channels. Similarly,
Fig. 3. Effects of diclofenac and bromophenacyl bromide on ICl(Ca). (A) Chemical structures of ACA (N-(p-amylcinnamoyl)anthranilic acid), anthranilic acid, flufenamic acid (2-
{[3-(trifluoromethyl)phenyl]amino}benzoic acid) and diclofenac (2-[2-(2,6-dichlorophenyl)aminophenyl]acetic acid). Notice the presence of the anthranilic acid moiety in
ACA and flufenamic acid, but a modified structure in diclofenac. (B) Traces of currents induced by voltage steps (inset) in a cell dialyzed with the standard internal solution
and superfused with Na+-free solution. Left panel: currents under control conditions. Middle panel: currents during extracellular application of diclofenac (50 lM). Right
panel: currents during application of flufenamic acid (100 lM) after diclofenac washout. (C) Similar protocol as in (B), but testing bromophenacyl bromide (BPB, 50 lM). (D)
Summary data of drug effects on the transient outward currents. P = 0.502 for diclofenac and P = 0.199 for BPB, compared with control currents (paired t-test).
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voltage clamp (not illustrated).
The concentration-response curve of ICl(Ca) obtained when using
different concentrations of ACA is illustrated in Fig. 2D. The effects
of ACA can be described by a 50% inhibitory concentration (IC50) of
4.2 lM and a Hill coefficient (nHill) of 1.1 (n = 4–6 for each
concentration).
3.3. Effects of the NSAID diclofenac and the PLA2 inhibitor
bromophenacyl bromide
Given that ACA and flufenamic acid are both fenamates and
share an inhibitory action on ICl(Ca), we wanted to find out whether
the fenamate-related drug, diclofenac, which is clinically used as a
non-steroidal anti-inflammatory drug (NSAID), also inhibits ICl(Ca).
Diclofenac (50 lM) did not suppress the transient outward current
(Fig. 3B; left versusmiddle panels), which at +60 mV was 105 ± 21%of control (Fig. 3D; P = 0.502 versus control; paired t-test, n = 5),
while in the same cells the current could be suppressed by flufen-
amic acid (100 lM; Fig. 3B, right panel). Similarly, 100 lM diclofe-
nac was ineffective in two other cells. In addition, because of the
known phospholipase A2 (PLA2) inhibitory effects of ACA [15], we
also tested whether the enzyme could be involved in the action
of ACA on ICl(Ca). The non-selective PLA2 inhibitor bromophenacyl
bromide (50 lM) failed to suppress the transient outward current,
which was 91 ± 11% of control (Fig. 3C and D; P = 0.199 versus con-
trol; paired t-test, n = 4), suggesting that ACA effect on ICl(Ca) is
PLA2-independent.
3.4. Effects of ACA on the cAMP-activated Cl current (ICl(cAMP))
Having shown that ACA inhibits ICl(Ca), we wanted to compare
its inhibitory effect on ICl(Ca) with its effect on another Cl current,
by testing its effect on the cAMP-activated current (ICl(cAMP)), also
A. Gwanyanya et al. / Biochemical and Biophysical Research Communications 402 (2010) 531–536 535present in cardiac ventricular myocytes [20]. For this purpose,
nifedipine (100 lM) was included in external solutions to block
ICa,L, Na+-containing, Cs+-based external solutions and the standard
Cs+-containing pipette solutions were used, and the voltage clamp
protocol consisted of ramps. The results are illustrated in Fig. 4.
Forskolin, which is known to increase cAMP, induced an out-
ward-rectifying current (1.4 ± 0.10 pA/pF at 120 mV and
3.9 ± 0.35 pA/pF at +80 mV) with reversal potential of
38.9 ± 1.7 mV (n = 5), practically identical with the calculated
equilibrium potential for Cl (40.1 mV) under our experimental
conditions. The outward component of the forskolin-activated cur-
rent could be suppressed by decreasing Clo , consistent with the
view that the current is due to Cl influx. ACA (50 lM) decreased
the forskolin-activated current to 55 ± 3% at 120 mV and to
68 ± 5% at +80 mV (P < 0.05 compared with the current in forskolin
alone; paired t-test, n = 5). The reversal potential for the ACA-sen-
sitive current was 35.6 ± 5.1 mV (P = 0.550 compared with the
reversal potential of the forskolin-induced current; paired t-test,
n = 5). Fig. 4B shows summary data of the above-mentioned effects
and also illustrates the current–voltage relationships. Given that at
50 lM ACA practically fully suppresses ICl(Ca) (see Fig. 2D), the drug
is therefore a less effective inhibitor of ICl(cAMP) than it is of ICl(Ca).
4. Discussion
In the present study we show that a Ca2+-activated Cl current
(ICl(Ca)) is present in pig ventricular myocytes and that it is inhib-
ited by N-(p-amylcinnamoyl)anthranilic acid (ACA). Our experi-
mental conditions, using Na+-free external solutions and K+-free
external and internal solutions, were designed to promote high
intracellular [Ca2+] levels ([Ca2+]i) and to suppress any eventual
K+-dependent transient outward current, respectively. We show
that depolarizing voltage steps to potentials positive to 40 mV in-
duce net inward currents that are short-lived and followed by tran-
sient outward currents. The latter currents were eliminated by
omitting Clo, by externally applying known Cl channel inhibitors
such as flufenamic acid or DIDS, or by increasing the intracellular
buffering of [Ca2+]i combined with an inhibition of Ca2+ release
from the sarcoplasmic reticulum. Thus, our data are consistent
with previous findings [19] showing the presence of ICl(Ca) in pig
ventricular myocytes.
Transient outward currents (Ito) play an important role in the
repolarization of the cardiac action potential. In most cases, Ito is
largely made of K+ currents through Kv4.x/Kv1.4 channels. How-
ever, the expression of these channels differs among species. The
currents are large in ventricular cells of rodents, but are absentFig. 4. Effects of ACA on the cAMP-activated chloride current. (A) Currents (at 120 and +
internal solution and superfused with Na+-containing solution, plotted as a function of tim
Cl, the anion was replaced by methylsulfate. Periods of drug application and of superfus
current–voltage relationships under control conditions (s), during forskolin applicatio
currents (at 120 and +80 mV) in forskolin plus ACA versus forskolin alone (paired t-tesor very small in ventricular myocytes of pig [17,19] and guinea-
pig [21]. There is still controversy concerning the mechanism
underlying this lack of Kv4.x/Kv1.4-based currents in pig ventricu-
lar cells, with one study reporting lack of protein expression [19],
whereas another showed their presence in non-conducting state
[22]. Within the heart, the expression of Kv4.x/Kv1.4 channels is
also region-dependent, being more prominent in subepicardial lay-
ers compared to mid-myocardial or subendocardial layers. The
other type of Ito found in cardiac cells is due to ICl(Ca), which we
studied here. Because of its nature, ICl(Ca) is expected to be more
prominent under conditions of intracellular Ca2+ overload. In a re-
cent study, we showed that ACA depolarizes cardiac myocytes and
also prolongs the action potential duration [23]. The latter effect of
ACA may be related, at least in part, to the inhibition of ICl(Ca).
At present, with the molecular identity of Ca2+-activated Cl
channels and their existence in the human heart still uncertain
[24,25], pharmacological agents continue to be a valuable tool in
evaluating the contribution of the channels to net ion currents
and to membrane potentials [1,10]. Our results show that ACA is
an additional useful tool to study ICl(Ca). The drug reversibly inhib-
ited ICl(Ca) without affecting ICa,L. This inhibitory action occurred in
a concentration range (IC50 = 4.2 lM) similar to the inhibition by
flufenamic or niflumic acids (IC50 range 2–108 lM; see [1]). De-
spite similar potencies, and despite the effect of ACA on other
channels, ACA may be more advantageous than fenamates when
studying ICl(Ca) because some of the latter drugs have been reported
to affect ICa,L. The above-mentioned depolarization is due to the
induction by ACA of a cation current [23], but this effect also occurs
with less potency (K0.5 = 24 lM) than the effect on ICl(Ca).
The mechanism underlying ACA effect on ICl(Ca) is unclear. ACA
is a known PLA2 inhibitor [15], but its effects on ICl(Ca) are likely
to be PLA2-independent because they could not be reproduced by
the non-selective PLA2 inhibitor bromophenacyl bromide. ACA
has also been recently shown to inhibit some transient receptor
potential (TRP) cation channels [26] in a PLA2-independent man-
ner. Flufenamic acid also inhibits several TRP channels (see [27]),
implying a common underlying mechanism of action. Indirect
mechanisms of inhibition of ICl(Ca) involving changes in Ca2+ are un-
likely given the lack of ACA effect on ICa,L. Rather, because ACA also
suppressed cAMP-activated Cl currents, the drug could be acting
as an anion channel inhibitor. Diclofenac, which is structurally-
related to fenamates and to ACA, did not have similar effects on
ICl(Ca), suggesting that structural differences between them may
confer specific properties.
In conclusion, the present study shows that ACA suppresses car-
diac ICl(Ca) in a concentration-dependent, but PLA2-independent80 mV), induced by ramps from 120 to +80 mV in a cell dialyzed with the standard
e. Forskolin (10 lM) and ACA (50 lM) were applied externally. For low extracellular
ion with low Cl solution are indicated by horizontal bars. (B) Summary data of the
n (d), and during ACA application on top of forskolin (j). *Indicates P < 0.05 for
t).
536 A. Gwanyanya et al. / Biochemical and Biophysical Research Communications 402 (2010) 531–536manner and without affecting ICa,L. The drug also suppresses cAMP-
activated Cl currents, but with a lower potency. ACA may, there-
fore, provide an additional experimental tool or serve as template
for the design and development of new drugs useful in modulating
anion channels.
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